PortfoliosLab logo

Antibe Therapeutics Inc. (ATE.TO)

Equity · Currency in CAD · Last updated Aug 11, 2022

Company Info

ISINCA0370255097
CUSIP037025509
SectorHealthcare
IndustryMedical Devices

ATE.TOShare Price Chart


Chart placeholderClick Calculate to get results

ATE.TOPerformance

The chart shows the growth of CA$10,000 invested in Antibe Therapeutics Inc. in Jun 2013 and compares it to the S&P 500 index or another benchmark. It would be worth nearly CA$1,127 for a total return of roughly -88.73%. All prices are adjusted for splits and dividends.


-20.00%-10.00%0.00%10.00%20.00%MarchAprilMayJuneJulyAugust
-6.08%
-7.17%
ATE.TO (Antibe Therapeutics Inc.)
Benchmark (^GSPC)

ATE.TOReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M3.33%8.28%
6M-8.82%-9.28%
YTD-6.06%-14.48%
1Y-58.94%-8.58%
5Y-6.14%8.22%
10Y-21.32%8.52%

ATE.TOMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20223.03%8.82%6.76%-16.46%4.55%-11.59%-1.64%3.33%
2021-4.33%28.99%4.95%-17.29%-1.19%-10.82%-8.63%-62.83%-4.76%-33.33%-13.75%-4.35%
202024.44%8.93%-0.00%14.75%10.00%-46.10%-10.84%5.41%-10.26%-2.86%20.59%-4.15%
2019-6.45%-5.17%3.64%22.81%-7.14%3.08%-16.42%41.07%-1.27%25.64%-22.45%18.42%
201868.97%4.08%70.59%-9.20%-1.27%-2.56%-21.05%-5.00%17.54%-10.45%-15.00%21.57%
201717.65%5.00%-4.76%-15.00%-41.18%-10.00%5.56%-10.53%5.88%5.56%47.37%3.57%
2016-8.33%-0.00%-24.24%12.00%-7.14%-3.85%28.00%53.13%-14.29%-11.90%-13.51%6.25%
2015-89.00%36.36%133.33%34.29%-27.66%-17.65%-28.57%-5.00%63.16%-3.23%33.33%-10.00%
201428.30%-4.41%26.15%-29.27%-1.72%-7.02%-15.09%11.11%-22.00%28.21%2.00%-1.96%
20130.00%-0.00%0.00%1.82%16.07%-3.08%-15.87%

ATE.TOSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Antibe Therapeutics Inc. Sharpe ratio is -1.09. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00MarchAprilMayJuneJulyAugust
-1.09
-0.42
ATE.TO (Antibe Therapeutics Inc.)
Benchmark (^GSPC)

ATE.TODividend History


Antibe Therapeutics Inc. doesn't pay dividends

ATE.TODrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugust
-92.71%
-14.96%
ATE.TO (Antibe Therapeutics Inc.)
Benchmark (^GSPC)

ATE.TOWorst Drawdowns

The table below shows the maximum drawdowns of the Antibe Therapeutics Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Antibe Therapeutics Inc. is 95.29%, recorded on Jan 26, 2015. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-95.29%Mar 24, 2014212Jan 26, 2015
-20%Aug 22, 201380Dec 13, 201332Jan 31, 2014112
-12.94%Mar 10, 20149Mar 20, 20141Mar 21, 201410
-8.7%Feb 18, 20146Feb 25, 20145Mar 4, 201411
-6.9%Jul 29, 201311Aug 13, 20136Aug 21, 201317

ATE.TOVolatility Chart

Current Antibe Therapeutics Inc. volatility is 61.64%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%MarchAprilMayJuneJulyAugust
61.64%
16.26%
ATE.TO (Antibe Therapeutics Inc.)
Benchmark (^GSPC)